Publications

Detailed Information

The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes

DC Field Value Language
dc.contributor.authorKim, Min-
dc.contributor.authorAhn, Byung Yong-
dc.contributor.authorLee, Ji Seon-
dc.contributor.authorChung, Sung Soo-
dc.contributor.authorPark, Sang Gyu-
dc.contributor.authorLee, Hong Kyu-
dc.contributor.authorPark, Kyong Soo-
dc.contributor.authorJung, Hye Seung-
dc.contributor.authorLim, Soo-
dc.date.accessioned2012-05-23T04:20:44Z-
dc.date.available2012-05-23T04:20:44Z-
dc.date.issued2009-11-06-
dc.identifier.citationBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Vol.389 1; 70-73ko_KR
dc.identifier.issn0006-291X-
dc.identifier.urihttps://hdl.handle.net/10371/76314-
dc.description.abstractThe ginsenoside Rg3 is known to have a protective effect against hyperglycemia, obesity and diabetes in vivo. In this study, we examined the effect of Rg3 on insulin signaling and glucose uptake in cultured L6 myotubes. Rg3 increased glucose uptake both in the basal and insulin-induced states of L6 myotubes. Consistent with the increase in glucose uptake, Rg3 stimulated the phosphorylation of IRS-1 and Akt. Interestingly, Rg3 dramatically increased IRS-1 protein levels, while the protein level of Akt was not affected. Rg3 regulated IRS-1 expression at the transcriptional level and also increased the level of GLUT4 mRNA. Treatment of ginsam, in which Rg3 is the major compound of ginsenosides, increased the IRS-1 protein levels in OLEFT rats. In addition, we found that this effect of Rg3 on insulin signaling was not mediated by the AMPK pathway. In conclusion, these results suggest that Rg3 improves insulin signaling and glucose uptake primarily by stimulating the expression of IRS-1 and GLUT4. (C) 2009 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCEko_KR
dc.subjectRg3ko_KR
dc.subjectGinsenosideko_KR
dc.subjectIRS-1ko_KR
dc.subjectInsulin signalingko_KR
dc.titleThe ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김민-
dc.contributor.AlternativeAuthor안병용-
dc.contributor.AlternativeAuthor이지선-
dc.contributor.AlternativeAuthor정성수-
dc.contributor.AlternativeAuthor임수-
dc.contributor.AlternativeAuthor박상규-
dc.contributor.AlternativeAuthor정혜승-
dc.contributor.AlternativeAuthor이홍규-
dc.contributor.AlternativeAuthor박경수-
dc.identifier.doi10.1016/j.bbrc.2009.08.088-
dc.citation.journaltitleBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-
dc.description.citedreferenceHwang JT, 2009, PHYTOTHER RES, V23, P262, DOI 10.1002/ptr.2606-
dc.description.citedreferenceLim S, 2009, METABOLISM, V58, P8, DOI 10.1016/j.metabol.2008.07.027-
dc.description.citedreferenceChoi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x-
dc.description.citedreferenceNakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334-
dc.description.citedreferenceHuang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200-
dc.description.citedreferenceKim JH, 2005, J PHARMACOL SCI, V97, P124-
dc.description.citedreferenceYun SN, 2004, ARCH PHARM RES, V27, P790-
dc.description.citedreferenceAttele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851-
dc.description.citedreferenceZheng DH, 2001, J APPL PHYSIOL, V91, P1073-
dc.description.citedreferenceCho H, 2001, SCIENCE, V292, P1728-
dc.description.citedreferenceSaltiel AR, 2001, CELL, V104, P517-
dc.description.citedreferenceCARVALHO E, 2001, FASEB J, V15, P1101-
dc.description.citedreferenceKubota N, 2000, DIABETES, V49, P1880-
dc.description.citedreferenceKido Y, 2000, J CLIN INVEST, V105, P199-
dc.description.citedreferenceBlair AS, 1999, J BIOL CHEM, V274, P36293-
dc.description.citedreferenceHolmes BF, 1999, J APPL PHYSIOL, V87, P1990-
dc.description.citedreferenceFriedman JE, 1999, DIABETES, V48, P1807-
dc.description.citedreferenceWang QH, 1999, MOL CELL BIOL, V19, P4008-
dc.description.citedreferenceVirkamaki A, 1999, J CLIN INVEST, V103, P931-
dc.description.citedreferenceWhite MF, 1998, MOL CELL BIOCHEM, V182, P3-
dc.description.citedreferenceGillis CN, 1997, BIOCHEM PHARMACOL, V54, P1-
dc.description.tc9-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share